JPH02117610A - Cosmetic containing capsule involving emulsion - Google Patents
Cosmetic containing capsule involving emulsionInfo
- Publication number
- JPH02117610A JPH02117610A JP27024088A JP27024088A JPH02117610A JP H02117610 A JPH02117610 A JP H02117610A JP 27024088 A JP27024088 A JP 27024088A JP 27024088 A JP27024088 A JP 27024088A JP H02117610 A JPH02117610 A JP H02117610A
- Authority
- JP
- Japan
- Prior art keywords
- capsule
- emulsion
- water
- cosmetic
- involving
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000002775 capsule Substances 0.000 title abstract description 41
- 239000002537 cosmetic Substances 0.000 title abstract description 28
- 239000000839 emulsion Substances 0.000 title abstract description 28
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 14
- -1 alginic acid salt Chemical class 0.000 abstract description 13
- 230000000694 effects Effects 0.000 abstract description 13
- 239000012528 membrane Substances 0.000 abstract description 11
- 235000010410 calcium alginate Nutrition 0.000 abstract description 10
- 239000000648 calcium alginate Substances 0.000 abstract description 10
- 229960002681 calcium alginate Drugs 0.000 abstract description 10
- OKHHGHGGPDJQHR-YMOPUZKJSA-L calcium;(2s,3s,4s,5s,6r)-6-[(2r,3s,4r,5s,6r)-2-carboxy-6-[(2r,3s,4r,5s,6r)-2-carboxylato-4,5,6-trihydroxyoxan-3-yl]oxy-4,5-dihydroxyoxan-3-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylate Chemical compound [Ca+2].O[C@@H]1[C@H](O)[C@H](O)O[C@@H](C([O-])=O)[C@H]1O[C@H]1[C@@H](O)[C@@H](O)[C@H](O[C@H]2[C@H]([C@@H](O)[C@H](O)[C@H](O2)C([O-])=O)O)[C@H](C(O)=O)O1 OKHHGHGGPDJQHR-YMOPUZKJSA-L 0.000 abstract description 10
- 239000003974 emollient agent Substances 0.000 abstract description 9
- 235000010443 alginic acid Nutrition 0.000 abstract description 6
- 229920000615 alginic acid Polymers 0.000 abstract description 6
- 239000006210 lotion Substances 0.000 abstract description 6
- 159000000007 calcium salts Chemical class 0.000 abstract description 3
- 238000007796 conventional method Methods 0.000 abstract description 3
- 239000000783 alginic acid Substances 0.000 abstract description 2
- 229960001126 alginic acid Drugs 0.000 abstract description 2
- 239000007864 aqueous solution Substances 0.000 abstract description 2
- 230000003796 beauty Effects 0.000 abstract 1
- 239000003921 oil Substances 0.000 description 12
- 235000019198 oils Nutrition 0.000 description 12
- 239000004615 ingredient Substances 0.000 description 11
- 239000000203 mixture Substances 0.000 description 10
- 230000003020 moisturizing effect Effects 0.000 description 10
- 235000014113 dietary fatty acids Nutrition 0.000 description 8
- 239000000194 fatty acid Substances 0.000 description 8
- 229930195729 fatty acid Natural products 0.000 description 8
- 239000007788 liquid Substances 0.000 description 8
- 239000012071 phase Substances 0.000 description 6
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 5
- 235000010413 sodium alginate Nutrition 0.000 description 5
- 239000000661 sodium alginate Substances 0.000 description 5
- 229940005550 sodium alginate Drugs 0.000 description 5
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 4
- 239000002585 base Substances 0.000 description 4
- 239000004359 castor oil Substances 0.000 description 4
- 235000019438 castor oil Nutrition 0.000 description 4
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 4
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 4
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerol Natural products OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 239000004166 Lanolin Substances 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 229940072056 alginate Drugs 0.000 description 3
- 235000019388 lanolin Nutrition 0.000 description 3
- 229940039717 lanolin Drugs 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 239000001993 wax Substances 0.000 description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 description 2
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 2
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 2
- 150000004781 alginic acids Chemical class 0.000 description 2
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- KXKPYJOVDUMHGS-OSRGNVMNSA-N chondroitin sulfate Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](OS(O)(=O)=O)[C@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](C(O)=O)O1 KXKPYJOVDUMHGS-OSRGNVMNSA-N 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 description 2
- 229940075507 glyceryl monostearate Drugs 0.000 description 2
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 2
- 239000010931 gold Substances 0.000 description 2
- 229910052737 gold Inorganic materials 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 2
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 2
- 239000002736 nonionic surfactant Substances 0.000 description 2
- 239000010466 nut oil Substances 0.000 description 2
- 235000019488 nut oil Nutrition 0.000 description 2
- 230000002688 persistence Effects 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 239000008213 purified water Substances 0.000 description 2
- 230000001953 sensory effect Effects 0.000 description 2
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 229940032094 squalane Drugs 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 229940058015 1,3-butylene glycol Drugs 0.000 description 1
- FDCJDKXCCYFOCV-UHFFFAOYSA-N 1-hexadecoxyhexadecane Chemical compound CCCCCCCCCCCCCCCCOCCCCCCCCCCCCCCCC FDCJDKXCCYFOCV-UHFFFAOYSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical class CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- WCVOGSZTONGSQY-UHFFFAOYSA-N 2,4,6-trichloroanisole Chemical compound COC1=C(Cl)C=C(Cl)C=C1Cl WCVOGSZTONGSQY-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 235000017788 Cydonia oblonga Nutrition 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 241000221095 Simmondsia Species 0.000 description 1
- 235000004433 Simmondsia californica Nutrition 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 150000003973 alkyl amines Chemical class 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- ZOJBYZNEUISWFT-UHFFFAOYSA-N allyl isothiocyanate Chemical compound C=CCN=C=S ZOJBYZNEUISWFT-UHFFFAOYSA-N 0.000 description 1
- 235000010407 ammonium alginate Nutrition 0.000 description 1
- 239000000728 ammonium alginate Substances 0.000 description 1
- KPGABFJTMYCRHJ-YZOKENDUSA-N ammonium alginate Chemical compound [NH4+].[NH4+].O1[C@@H](C([O-])=O)[C@@H](OC)[C@H](O)[C@H](O)[C@@H]1O[C@@H]1[C@@H](C([O-])=O)O[C@@H](O)[C@@H](O)[C@H]1O KPGABFJTMYCRHJ-YZOKENDUSA-N 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 238000003287 bathing Methods 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- YPQBHUDKOKUINZ-OLXYHTOASA-L bismuth;sodium;(2r,3r)-2,3-dioxidobutanedioate Chemical compound [Na+].[Bi+3].[O-]C(=O)[C@H]([O-])[C@@H]([O-])C([O-])=O YPQBHUDKOKUINZ-OLXYHTOASA-L 0.000 description 1
- 235000019437 butane-1,3-diol Nutrition 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 235000011148 calcium chloride Nutrition 0.000 description 1
- FNAQSUUGMSOBHW-UHFFFAOYSA-H calcium citrate Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O FNAQSUUGMSOBHW-UHFFFAOYSA-H 0.000 description 1
- 239000001354 calcium citrate Substances 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 235000011132 calcium sulphate Nutrition 0.000 description 1
- 239000004204 candelilla wax Substances 0.000 description 1
- 235000013868 candelilla wax Nutrition 0.000 description 1
- 229940073532 candelilla wax Drugs 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 239000008341 cosmetic lotion Substances 0.000 description 1
- JVSWJIKNEAIKJW-UHFFFAOYSA-N dimethyl-hexane Natural products CCCCCC(C)C JVSWJIKNEAIKJW-UHFFFAOYSA-N 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 238000005538 encapsulation Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- LYCAIKOWRPUZTN-UHFFFAOYSA-N ethylene glycol Natural products OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 238000007667 floating Methods 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- IUJAMGNYPWYUPM-UHFFFAOYSA-N hentriacontane Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC IUJAMGNYPWYUPM-UHFFFAOYSA-N 0.000 description 1
- OIKBVOIOVNEVJR-UHFFFAOYSA-N hexadecyl 6-methylheptanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)CCCCC(C)C OIKBVOIOVNEVJR-UHFFFAOYSA-N 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- 239000004200 microcrystalline wax Substances 0.000 description 1
- 235000019808 microcrystalline wax Nutrition 0.000 description 1
- 239000008164 mustard oil Substances 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 235000010408 potassium alginate Nutrition 0.000 description 1
- 239000000737 potassium alginate Substances 0.000 description 1
- MZYRDLHIWXQJCQ-YZOKENDUSA-L potassium alginate Chemical compound [K+].[K+].O1[C@@H](C([O-])=O)[C@@H](OC)[C@H](O)[C@H](O)[C@@H]1O[C@@H]1[C@@H](C([O-])=O)O[C@@H](O)[C@@H](O)[C@H]1O MZYRDLHIWXQJCQ-YZOKENDUSA-L 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- QAZCPUUJMFBNJO-UHFFFAOYSA-N pyrrolidin-2-one;sodium Chemical compound [Na].O=C1CCCN1 QAZCPUUJMFBNJO-UHFFFAOYSA-N 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- 239000001540 sodium lactate Substances 0.000 description 1
- 229940005581 sodium lactate Drugs 0.000 description 1
- 235000011088 sodium lactate Nutrition 0.000 description 1
- 238000005063 solubilization Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 235000013337 tricalcium citrate Nutrition 0.000 description 1
- 229940099259 vaseline Drugs 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/11—Encapsulated compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/733—Alginic acid; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/41—Particular ingredients further characterized by their size
- A61K2800/412—Microsized, i.e. having sizes between 0.1 and 100 microns
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
Abstract
Description
【発明の詳細な説明】
〔産業上の利用分野〕
本発明は、0/W型エマルシヨン金内包したアルギン酸
カルシウム膜のカプセルを含有し、湿潤効果及びエモリ
エント効果を同時に付与することができる新規な形態の
エマルション内包カブセル含有化粧料に関する。DETAILED DESCRIPTION OF THE INVENTION [Field of Industrial Application] The present invention is a novel form containing capsules of calcium alginate film encapsulating O/W emulsion gold and capable of imparting moisturizing and emollient effects at the same time. The present invention relates to a cosmetic containing an emulsion-encapsulated capsule.
従来、γ出仕と水分金倉む化粧料としては、乳化型、o
T溶化型、多ノー型が知られている。Conventionally, cosmetics that contain gamma and moisture content have been emulsified, o
T-solubilization type and multi-no type are known.
これらのうち、乳化型化粧料(エマルション類)は、肌
に油分を補うことはできるが、エマルション界面に影#
金及ぼす成分、例えば多量の電解質成分を配合すると乳
化間が不安定となり、その結果、これら成分による光分
な保湿・湿潤効果が期待できなかった。Among these, emulsion-type cosmetics (emulsions) can supplement oil to the skin, but they leave a negative impact on the emulsion interface.
When a large amount of a metallic component, such as an electrolyte component, is added, the emulsion becomes unstable, and as a result, it is not possible to expect the effective moisturizing and moisturizing effects of these components.
また、可溶化型化粧料(化粧水類)は、肌に対する湿潤
効果を付与することはできるが。Furthermore, solubilized cosmetics (lotions) can impart a moisturizing effect to the skin.
配合できる油分が比較的少なく、光分なエモリエント効
果を付与できるものではなかった。The amount of oil that can be blended is relatively small, and it is not possible to impart a light emollient effect.
そして、水相と油相が分離した状態の多層型化粧料は、
湿潤効果及びエモリエント効果を同時に肌に付与するこ
とが可能である。しかしながら、使用時に蚕とうすると
容易に均一混和状態となシ、シかも静置時にきれいな分
離状態を呈するものを得るためには、油相成分や水相成
分の選択、 1m141が困難でアシ、符に油相成分と
して液体油を多く用いることから、官能面での使用感触
の拡がシが充分満足できるものではなく、さらに使用時
にムラ付きしたり、肌へのなじみが悪いという欠点がめ
った。Multi-layer cosmetics, in which the water phase and oil phase are separated,
It is possible to provide the skin with a moisturizing effect and an emollient effect at the same time. However, it is difficult to select the oil phase component and water phase component, and it is difficult to obtain a product that exhibits a clean separation state when left to stand. Since a large amount of liquid oil is used as an oil phase component, the spread of the sensory sensation during use is not fully satisfactory, and furthermore, there are frequent drawbacks such as unevenness during use and poor adhesion to the skin.
−1、油分を小球状にして水相に分散配合したシ、油性
成分又は水性成分を合成高分子やゼラチン膜を用いてカ
プセル化し、水相又は油相に分散配合する試みがなされ
ている。-1. Attempts have been made to form oil into small spheres and disperse and blend them into an aqueous phase. Attempts have been made to encapsulate oily or aqueous components using synthetic polymers or gelatin membranes and disperse and blend them into an aqueous or oil phase.
しかし、油分を小球状にして分散した場合。However, if the oil is dispersed in small spheres.
長期間安定性を維持することができず、またカプセル化
して配合した場合は、使用時にカプセル膜が机上KIA
つた。b、g造が容易でないという問題がめった。If it is not possible to maintain stability for a long period of time, and if it is formulated in encapsulation, the capsule membrane will be
Ivy. b, g There was a rare problem that construction was not easy.
このため、化粧水類の特性を活かし、湿潤効果とエモリ
エント効果を合わせもった製品の開発、さらに多様化す
る消費者のニーズに応えた製品化が望まれていた。For this reason, there has been a desire to develop products that take advantage of the characteristics of lotions and have both moisturizing and emollient effects, and to commercialize products that meet the diversifying needs of consumers.
斯かる実情において1本発明者は鋭意研究を行った結果
、0/W型エマルシヨンを内包L7’cアルギン酸カル
シウム膜のカプセルt−含有した化粧料は、経時安定性
が良好でるり、しかも湿潤効果とエモリエント効果を同
時に付与できることを見出し、本発明を完成した。Under these circumstances, the present inventor conducted intensive research and found that a cosmetic containing capsules of L7'c calcium alginate film containing O/W type emulsion has good stability over time and has a moisturizing effect. They discovered that it is possible to simultaneously impart an emollient effect and an emollient effect, and completed the present invention.
すなわち、本発明は、O/Wfiエマルションを内包し
たカプセルを含有する化粧料でろって、カシセル膜がカ
プセル全量に対し0.1〜1.0重量%のアルギン酸カ
ルシウムから成ること’t%徴とするエマルション内包
カプセル含有化粧料を提供するものである。That is, the present invention provides a cosmetic containing a capsule containing an O/Wfi emulsion, in which the cassicle membrane is composed of 0.1 to 1.0% by weight of calcium alginate based on the total amount of the capsule. The present invention provides a cosmetic containing an emulsion encapsulating capsule.
本発明において、カプセルに内包させるエマルションは
0/W型のものでめシ、通常の化粧料に使用できる油性
成分、水性成分及び界面活性剤を含んで構成され、これ
は常法によって調製される。In the present invention, the emulsion to be encapsulated in the capsule is of 0/W type and is composed of rice, an oily component that can be used in ordinary cosmetics, an aqueous component, and a surfactant, and is prepared by a conventional method. .
斯かる油性成分としては、天然、合成を問わず、また液
体、半固体及び固体のものが使用でき1例えばオリーブ
油、ホホバ油、マカデミアンナッツ油、ヒマシ油などの
植物油類:ミツロウ、キャンデリラロウ、モクロウなど
のロウn;fLmノ9ラフイン、スクヮラン、ワセリン
、ノQラフインワックス、マイクロクリスタリンワック
スなどの炭化水素類ニトリイソオクタン酸グリセリル、
モノステアリン酸グリセリン、イソオクタン戚セチルな
どのエステル類;シリコーン油類;ラノリンなどを挙け
ることができる。これらは単独、または二櫨以上を組み
仕わせて用いることができる。Such oily ingredients may be natural or synthetic, and may be liquid, semi-solid, or solid. For example, vegetable oils such as olive oil, jojoba oil, macadamian nut oil, and castor oil; beeswax, candelilla wax; Hydrocarbons such as wax n; fLm no 9 rough-in wax, squalane, vaseline, No-Q rough-in wax, and microcrystalline wax; glyceryl nitriisooctoate;
Examples include esters such as glyceryl monostearate and cetyl isooctane; silicone oils; and lanolin. These can be used alone or in combination of two or more.
また、界面活性剤としては、非イオン性、陰イオン性、
陽イオン性1両性のものt−使用することができるが、
皮膚刺[、アルギン酸カルシウムのカプセル膜形成への
影参などの点から、%に非イオン性界面活性剤が好まし
い。非イオン性界面活性剤としては、例えばデカグリセ
リン脂肪酸エステル、ボ゛リグリセリン脂肪酸エステル
%づeリオキシエチレンンルビタン脂肪酸エステ、fl
l、l’リオキシ3?チレンンルビット脂肪酸エステル
、?リオキシエチレングリセリン脂肪酸エステル、?リ
エチレングリコール脂肪酸J−,ステル、?リオキシエ
チレンアルキルエ・−チル、?リオキシエチレンフイト
ステロール、Ti?リオキシエチレンフイトスタノール
、?リオキシエチレンポリオキシfeeレンアルキルエ
ーデル、?リオキシエテ17ンアルキルフエエルエーテ
ル、4Pリオキシエチレンとマシ油、?リオキシエチレ
ン硬化ヒマシ油、?リオキシエチレンラノリン、?リオ
キシエチレンラノリンアルコ−ル、〆リオキシエチレン
アルキルアミン、?リオキシエチレン脂肪酸アミド、シ
ョ糖脂肪酸エステルなどが挙げられる。In addition, surfactants include nonionic, anionic,
Cationic and amphoteric ones can be used, but
Nonionic surfactants are preferred from the viewpoint of skin irritation and the influence of calcium alginate on capsule membrane formation. Examples of the nonionic surfactant include decaglycerin fatty acid ester, polyglycerin fatty acid ester, polyoxyethylene rubitan fatty acid ester, and fl.
l, l'lioxy 3? Tyrene Rubit fatty acid ester? Lyoxyethylene glycerin fatty acid ester? Liethylene glycol fatty acid J-, stell,? Lyoxyethylene alkyl ethyl? Lyoxyethylene phytosterol, Ti? Lyoxyethylene phytostanol? Lyoxyethylene polyoxy fee lene alkyl edel,? Lioxyethene 17-alkyl ether, 4P lyoxyethylene and mustard oil, ? Lioxyethylene hydrogenated castor oil? Lyoxyethylene lanolin? Lioxyethylene lanolin alcohol, 〆lioxyethylene alkylamine, ? Examples include lyoxyethylene fatty acid amide and sucrose fatty acid ester.
これら成分の他1本発明における0/W型エマルシヨン
には1通常の化粧料に用いられる成分1例えば紫外線技
収剤、保湿剤、アルコール類、防腐剤、水浴性高分子、
色素、査料なとを必要に応じ−AM配合することができ
る。In addition to these ingredients, the O/W type emulsion in the present invention includes ingredients used in ordinary cosmetics, such as ultraviolet absorbers, humectants, alcohols, preservatives, bathing polymers,
A dye, a test material, etc. can be added to -AM as necessary.
本発明においで、カシセル膜は水maアルギン酸塩と水
浴性カルシウム瓜金反応させて水不溶性のアルギン威カ
ルシウム?生成させることによシ形成される。水溶性ア
ルギン酸4とし、ては、例えばアルギン酸カリウム、ア
ルギン酸ナトリウムなどのアルカリ金属塩;アルギン酸
トリエタノールアミン、アルギン酸アンモニウムなどの
アミン塩などが用いられ、これらアルギン酸の分子tは
約X0OOOO〜300000のものが好ましい。また
、水浴性カルシウム塩としては1例えば塩化カルシウム
h 硫酸カルシウム、クエン酸カルシウム、リン酸カル
シウムなどが用いられる。In the present invention, the Cassicell membrane is made of water-insoluble alginate by reacting water-based calcium alginate with water-based calcium alginate. It is formed by generating. As the water-soluble alginic acid 4, for example, alkali metal salts such as potassium alginate and sodium alginate; amine salts such as triethanolamine alginate and ammonium alginate are used, and the molecule t of these alginic acids is about X0OOOO to 300000. preferable. Further, as the water-bathable calcium salt, for example, calcium chloride, calcium sulfate, calcium citrate, calcium phosphate, etc. are used.
アルギン酸カルシウムF′i、、カブセル金貸に対し0
.1〜1.0嵐盪チ(以り単にチで示す)用いることが
好ましい。0.1チ未満では安定性のめる膜が得られず
、1.0チを越えると使用時に膜が版上に残渣として残
ってしまう。Calcium alginate F′i, 0 for capsule moneylender
.. It is preferable to use 1 to 1.0 arashi (hereinafter simply indicated by ``chi''). If it is less than 0.1 inch, a stable film cannot be obtained, and if it exceeds 1.0 inch, the film will remain as a residue on the plate during use.
0/W型、エマルション内包カプセルは、例えば次の如
くして、、4製することができる。The 0/W type emulsion-containing capsule can be manufactured, for example, as follows.
■水溶性アルギン酸塩を宮んだO7W型エマルションを
常法によシ調製する。■Prepare an O7W type emulsion containing water-soluble alginate by a conventional method.
■■のエマルションを水浴性カルシウム塩の水′mg中
に滴下し、エマルション含有カプセル上生成させる。The emulsion of ■■ is dropped into 1000 mg of water containing a water-bathable calcium salt, and the emulsion is formed on the emulsion-containing capsule.
■滴下後、10〜60分間償伴して適当な大きさに分粒
し、次いで水で洗浄する。(2) After dropping, the particles are allowed to stand for 10 to 60 minutes to be divided into appropriate sizes, and then washed with water.
なお、カプセルの大きさは、關Fスピード。In addition, the size of the capsule is 關F speed.
部下時のノズル径に比例するが、lば径約O41〜5m
程度のものが得られる。−!た生成したカプセルは、乾
燥すると壊れやすくなるため水浴液甲に保存す゛るか、
直ちに使用に供することが必要でめる。It is proportional to the nozzle diameter when lower, but the diameter is about 041~5m.
You can get something like that. -! The capsules produced will be fragile when dried, so they should be stored in a water bath or
It is necessary to put it into use immediately.
叙上の如くして得られたUlW型エマルション内包カプ
セルを化粧料、基剤に配合することにより、本発明の化
粧料1得ることかできる。エマルション内包カプセルの
配合量は特に限定されず、目的に応じて設定することが
できる。また、化粧料基剤としては、特に限定されるも
のではないが、水性基剤に配合して、化粧水、化M!E
g等とした場合に特に優れた効果を奏する。なお1本発
明の化粧料には、通常の化粧料に用いられる成分を、必
要に応じ適宜配合することができる。Cosmetic composition 1 of the present invention can be obtained by blending the UlW type emulsion-containing capsule obtained as described above into a cosmetic composition or base. The blending amount of the emulsion-containing capsule is not particularly limited, and can be set depending on the purpose. In addition, as a cosmetic base, there are no particular limitations, but it can be blended with an aqueous base to create a lotion, Chemical M! E
Particularly excellent effects can be achieved when it is set to g or the like. Note that the cosmetic composition of the present invention may contain ingredients used in ordinary cosmetic compositions as appropriate.
本発明の化粧料は、エマルション内包カプセルが上層部
に浮遊した二層状態、るるいは比重や基剤の粘度t’s
整することによシカプセルが均一に安定分散した状態な
どとすることができる。The cosmetic of the present invention has a two-layer state in which the emulsion-containing capsules are suspended in the upper layer, and the specific gravity and viscosity of the base material are t's.
By adjusting the temperature, the capsules can be uniformly and stably dispersed.
以下、実施例を挙げて本発明を説明するが、本発明はこ
れら実施例に限定されるものではない。The present invention will be described below with reference to Examples, but the present invention is not limited to these Examples.
0/V#llエマルシヨン含有アルギン酸カルシウムカ
プセルのtA*:
くカプセルl〉
(成分)
(1)スクワラン □0.0(
2)トリイソオクタン酸グリセリル
10.0(3)セタノール
i、。0/V#ll emulsion-containing calcium alginate capsule tA*: Capsule l> (Ingredients) (1) Squalane □0.0 (
2) Glyceryl triisooctoate
10.0(3) Setanol
i.
(4)水添レシチン 1.0(5
)モノステアリン酸グリセリン 0.2
(6)モノオレイ7m(POE20)7にビタ7
2.0(7)アルギン酸ナトリウム(分子量約12
0000) 0.5(8)精製水
残量
(#!法)
成分(1)〜(6)を加熱混合し、これに予め加熱浴解
した成分(7)〜(8)を加えて乳化し、冷却する。生
成したエマルションを注射器に充填し、該エマルション
の5倍量の1%塩化カルシウム水溶液に滴下し、30分
間攪拌後、カプセルを得た。次いでこれを濾別し、水f
c後、水中に保存した。(4) Hydrogenated lecithin 1.0 (5
) Glyceryl monostearate 0.2
(6) Monolay 7m (POE20) 7 and Vita 7
2.0(7) Sodium alginate (molecular weight approx. 12
0000) 0.5(8) Purified water
Remaining Amount (#! Method) Components (1) to (6) are heated and mixed, and components (7) to (8), which have been previously dissolved in a heating bath, are added thereto to emulsify and cooled. The resulting emulsion was filled into a syringe, and added dropwise to a 1% aqueous calcium chloride solution in an amount five times the amount of the emulsion, and after stirring for 30 minutes, capsules were obtained. This was then filtered and water
After c, it was stored in water.
くカプセル2〉
(成分)
(1)マカデミアンナッツ油
5.0(2)ホホバ?11
5.0(3)コレステロール
0.5(4)イソオクタン酸セチル
5.0(5)流動/Qラフイン
10.0(6)トリyFVイアfll(PO
E20)7にピl17 1.0(ηPOE(1
0)POP(4)セチルエーテル 0.5(g
)POE(20)硬化ヒマシ油 1
.0(9)アルギン酸ナトリウム(分子量約20000
0) 0.2Ql)精製水 残量
(製法)
エマルションQIO倍tの2%m酸カルシウム水溶液に
滴下した以外はカプセル1と同様にして、カプセルヲ得
た。Capsule 2> (Ingredients) (1) Macadamian nut oil
5.0 (2) Jojoba? 11
5.0 (3) Cholesterol
0.5(4) Cetyl isooctanoate
5.0 (5) Flow/Q rough-in
10.0(6) TriyFViafull(PO
E20)7 to Pill17 1.0(ηPOE(1
0) POP (4) Cetyl ether 0.5 (g
) POE (20) Hydrogenated castor oil 1
.. 0(9) Sodium alginate (molecular weight approximately 20,000
0) 0.2Ql) Purified water Remaining amount (manufacturing method) Capsules were obtained in the same manner as capsule 1 except that the emulsion was added dropwise to a 2% calcium acid aqueous solution of t times the amount of emulsion QIO.
実施例1
第1表に示す組成の化粧g、をV@製し、経時安定性、
カプセル膜残存性及び使用感について評価した。結果を
第1表に示す。Example 1 Makeup g having the composition shown in Table 1 was manufactured by V@, and the stability over time was
Capsule membrane persistence and usability were evaluated. The results are shown in Table 1.
(#!法)
成分(1)〜acjt均一混合し、これに成分(111
〜15の中からそれぞれのカプセル膜残存性して化粧液
金得た。(#! Method) Components (1) to acjt are mixed uniformly, and component (111
Cosmetic liquid gold was obtained from capsule membrane persistence of each of ~15 to 15.
(評価方法)
経時安定性:40℃、1ケ月間放置後観察○ 変化なく
良好
X カプセルの破損
カプセル膜残存性−使用後の肌へのカシセル膜残渣の残
シ
Q なしく感じない)
× め#)(感じる)
使用感−使用後の肌へのしっとり感
○ めり
X なし
以下余白
*l:l:カプセルおいて、成分(1)〜(6)を除キ
、エマルションを含まないモノ
*2:カシセルlにおいて、成分(7)のアルギン酸ナ
トリウムt−0,05%とし友もの*3:カシセルlに
おいて、成分(7)のアルギン酸ナトリウムt−1,5
%としたもの本発明品は、放置すると透明液体の上部に
白いカシセルが浮遊した二層状態を呈し、使用時に振と
うするとカシセルが容易に均一分散する新規な形態の化
粧液でるる。そして、使用時に振とうしてもカプセルが
破損することがなく、経時安定性が良好でろシ、また使
用後に肌へカプセル膜が残らず、しかも湿潤効果及びエ
モリエント効果を併せて付与できるものでめった。(Evaluation method) Stability over time: Observation after leaving at 40°C for 1 month ○ Good with no change #) (feel) Feeling of use - Moist feeling on the skin after use ○ Melli 2: In Kasisel I, component (7) sodium alginate t-0.05% *3: In Kasisel I, component (7) sodium alginate t-1,5
% The product of the present invention is a cosmetic liquid with a new form, which exhibits a two-layered state with white cassissels floating on top of a transparent liquid when left to stand, and where cassicels are easily and uniformly dispersed when shaken before use. In addition, the capsule does not break even when shaken during use, has good stability over time, does not leave a capsule membrane on the skin after use, and is rare in that it has both a moisturizing effect and an emollient effect. .
実施例2 化粧液:
(成分)
(1)クエン酸
(2)クエン酸ナトリウム
(3)乳酸ナトリウム
(4)ビロリドンカルゴン酸ナトリウム(5)コンドロ
イチン硫酸ナトリウム
(6) 1 、3−ブチレングリコール(7)?リアク
リル酸ナトリウム
(8)セタノール
(9)香 科
uePOE(60)硬化ヒマシ油
aυビタミンE
aクカゾセル2
(1:1ff裂水
(至)
0.1
0.4
0.8
0.5
o、o o 5
lOoo
0、O5
5,0
0、Ol
2.0
0.1
3.0
残量
(:M法)
成分(1)〜(7)及びu2〜(131を混合し、これ
に予め混合溶解した成分(8)〜Ut−添加して化粧液
を得た。Example 2 Cosmetics: (Ingredients) (1) Citric acid (2) Sodium citrate (3) Sodium lactate (4) Sodium pyrrolidone cargonate (5) Sodium chondroitin sulfate (6) 1,3-Butylene glycol ( 7)? Sodium lyacrylate (8) Setanol (9) Aroma uePOE (60) Hydrogenated castor oil aυ Vitamin E a Kukazocel 2 (1:1ff Fissure water (to) 0.1 0.4 0.8 0.5 o, o o 5 lOoo 0, O5 5,0 0, Ol 2.0 0.1 3.0 Remaining amount (:M method) Components (1) to (7) and u2 to (131) were mixed and dissolved in advance. Ingredients (8) to Ut- were added to obtain a cosmetic liquid.
以上の如くして得た化粧液は、上層部にカプセルが浮遊
した二層状態を呈した新規形態のものであシ、使用時振
とうして肌に塗布することでしつとシ感の付与と油分補
給ができるものでめった。The cosmetic lotion obtained as described above has a new form with a two-layered structure in which capsules are suspended in the upper layer.When used, it is shaken and applied to the skin, giving it a firm and moist feeling. It was rare to find something that could replenish oil.
実施例3 化粧液:
(成分)
(1)タルトロール 0.2(2
)マルメロ迫出@0.1
(3)アルグコロイド 0.05(
4)グリセリン I O,0(5
)プロピレングリコール 3.0(6)
防腐剤 0.1
(ηカプセル15.0
(8)f!製水 残量
(製法)
成分(1)〜(6)及び(8)を混合し、これに(7)
を添加して分散する。以上の如くして得た化粧液は、カ
プセルがm液中に均一分散した状態を呈した新規形態の
ものでめシ、使用時肌にしつとシ感の付与と油分補給が
できるものでめった。Example 3 Cosmetics: (Ingredients) (1) Tartrol 0.2 (2
) Quince extrusion @0.1 (3) Algcolloid 0.05 (
4) Glycerin I O,0 (5
) Propylene glycol 3.0 (6)
Preservative 0.1 (η Capsule 15.0 (8) f! Water production remaining amount (manufacturing method) Mix ingredients (1) to (6) and (8), and add (7) to this.
Add and disperse. The cosmetic liquid obtained as described above has a novel form in which the capsules are uniformly dispersed in the m liquid, and is effective in imparting a moisturizing feeling to the skin and replenishing oil when used.
本発明のエマルション内包カプセル含有化粧料は、従来
の化粧水類では配合し峻かった油性成分を攬類を問わず
にエマルションとして配合することができるため、湿潤
効果とエモリエント効果を同時に付与できるとともに、
官能面での使用感の拡がシを図ることができる。また、
経時安定性が良好であシ、シかも使用時にカプセル膜が
肌に残ることもなく違和感もない。The emulsion-encapsulating capsule-containing cosmetic composition of the present invention can contain oil-based ingredients, which were difficult to incorporate in conventional lotions, as an emulsion regardless of the type of lotion, so it can simultaneously impart a moisturizing effect and an emollient effect. ,
It is possible to expand the sense of use in terms of sensory aspects. Also,
It has good stability over time, and when used, the capsule membrane does not remain on the skin and does not cause any discomfort.
さらに、本発明の化粧料はエマルション内包カプセルが
均一に安定分散した状態メるいは上層部に浮遊した二層
状態をとることができ、外観的にも新規な形態を有する
ものでるる。Furthermore, the cosmetic composition of the present invention can have a two-layered state in which the emulsion-containing capsules are uniformly and stably dispersed or suspended in the upper layer, and has a novel form in terms of appearance.
以上that's all
Claims (1)
る化粧料であつて、カプセル膜がカプセル全量に対し0
.1〜1.0重量%のアルギン酸カルシウムから成るこ
とを特徴とするエマルション内包カプセル含有化粧料。1. A cosmetic containing a capsule containing an O/W emulsion, in which the capsule membrane is 0% of the total amount of the capsule.
.. A cosmetic containing an emulsion encapsulating capsule, characterized by comprising 1 to 1.0% by weight of calcium alginate.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP27024088A JP2619705B2 (en) | 1988-10-26 | 1988-10-26 | Emulsion-encapsulated capsule-containing cosmetic |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP27024088A JP2619705B2 (en) | 1988-10-26 | 1988-10-26 | Emulsion-encapsulated capsule-containing cosmetic |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH02117610A true JPH02117610A (en) | 1990-05-02 |
JP2619705B2 JP2619705B2 (en) | 1997-06-11 |
Family
ID=17483507
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP27024088A Expired - Fee Related JP2619705B2 (en) | 1988-10-26 | 1988-10-26 | Emulsion-encapsulated capsule-containing cosmetic |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2619705B2 (en) |
Cited By (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0592909A (en) * | 1991-06-26 | 1993-04-16 | Sansho Kaken Kk | Cosmetic and toiletry containing the same |
US6391288B1 (en) | 1999-07-27 | 2002-05-21 | Shiseido Co., Ltd. | Microcapsule and method of making the same |
JP2004269502A (en) * | 2003-02-19 | 2004-09-30 | Kose Corp | Oil in water type emulsion cosmetic |
JP2006111620A (en) * | 2004-09-16 | 2006-04-27 | Kose Corp | Oil-in-water type liquid composition |
JP2010043047A (en) * | 2008-08-18 | 2010-02-25 | Sansho Kaken Kk | Cleansing agent |
US20100112073A1 (en) * | 2007-05-07 | 2010-05-06 | Sabliov Cristina M | Water-Soluble Nanoparticles Containing Water-Insoluble Compounds |
US8017046B2 (en) | 2000-06-30 | 2011-09-13 | Kao Corporation | Skin cosmetic composition |
WO2012035870A1 (en) | 2010-09-17 | 2012-03-22 | 株式会社資生堂 | Skin cosmetic |
JP2013139419A (en) * | 2011-12-30 | 2013-07-18 | Sansho Kaken Kk | Method for producing softgel type external preparation, softening liquid, and softgel type external preparation |
US8618171B2 (en) | 2006-01-18 | 2013-12-31 | Ajinomoto Co., Inc. | Encapsulated oil-in-water type emulsion composition |
US9642813B2 (en) | 2013-06-25 | 2017-05-09 | Sansho Kaken Kabushiki Kaisha | Method for producing soft capsule type external preparation, softening liquid, and soft capsule type external preparation |
JPWO2017090214A1 (en) * | 2015-11-25 | 2018-11-15 | アサヌマ コーポレーション株式会社 | Capsule manufacturing method |
JP2019131504A (en) * | 2018-01-31 | 2019-08-08 | 伯東株式会社 | Capsule and production method thereof, and encapsulated cosmetic and production method thereof |
JP2021088542A (en) * | 2019-12-04 | 2021-06-10 | 雅子 加藤 | Granular shampoo and method for producing the same |
WO2023037900A1 (en) * | 2021-09-10 | 2023-03-16 | 株式会社 資生堂 | Capsuled cosmetic material |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102317099B1 (en) * | 2014-11-27 | 2021-10-25 | 주식회사 엘지생활건강 | Cosmetic composition designed for breaking up algin capsule using chelating effect polymer |
-
1988
- 1988-10-26 JP JP27024088A patent/JP2619705B2/en not_active Expired - Fee Related
Cited By (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0592909A (en) * | 1991-06-26 | 1993-04-16 | Sansho Kaken Kk | Cosmetic and toiletry containing the same |
US6391288B1 (en) | 1999-07-27 | 2002-05-21 | Shiseido Co., Ltd. | Microcapsule and method of making the same |
US8017046B2 (en) | 2000-06-30 | 2011-09-13 | Kao Corporation | Skin cosmetic composition |
JP2004269502A (en) * | 2003-02-19 | 2004-09-30 | Kose Corp | Oil in water type emulsion cosmetic |
JP2006111620A (en) * | 2004-09-16 | 2006-04-27 | Kose Corp | Oil-in-water type liquid composition |
US8618171B2 (en) | 2006-01-18 | 2013-12-31 | Ajinomoto Co., Inc. | Encapsulated oil-in-water type emulsion composition |
US9707185B2 (en) * | 2007-05-07 | 2017-07-18 | Board Of Supervisors Of Louisana State University And Agricultural And Mechanical College | Water-soluble nanoparticles containing water-insoluble compounds |
US20100112073A1 (en) * | 2007-05-07 | 2010-05-06 | Sabliov Cristina M | Water-Soluble Nanoparticles Containing Water-Insoluble Compounds |
JP2010043047A (en) * | 2008-08-18 | 2010-02-25 | Sansho Kaken Kk | Cleansing agent |
WO2012035870A1 (en) | 2010-09-17 | 2012-03-22 | 株式会社資生堂 | Skin cosmetic |
JP2013139419A (en) * | 2011-12-30 | 2013-07-18 | Sansho Kaken Kk | Method for producing softgel type external preparation, softening liquid, and softgel type external preparation |
US9642813B2 (en) | 2013-06-25 | 2017-05-09 | Sansho Kaken Kabushiki Kaisha | Method for producing soft capsule type external preparation, softening liquid, and soft capsule type external preparation |
JPWO2017090214A1 (en) * | 2015-11-25 | 2018-11-15 | アサヌマ コーポレーション株式会社 | Capsule manufacturing method |
JP2019131504A (en) * | 2018-01-31 | 2019-08-08 | 伯東株式会社 | Capsule and production method thereof, and encapsulated cosmetic and production method thereof |
JP2021088542A (en) * | 2019-12-04 | 2021-06-10 | 雅子 加藤 | Granular shampoo and method for producing the same |
WO2023037900A1 (en) * | 2021-09-10 | 2023-03-16 | 株式会社 資生堂 | Capsuled cosmetic material |
Also Published As
Publication number | Publication date |
---|---|
JP2619705B2 (en) | 1997-06-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPH02117610A (en) | Cosmetic containing capsule involving emulsion | |
JPH05201845A (en) | Manufacture of personal article blended with scent | |
JPH07509177A (en) | Cosmetic composition in the form of a water/oil/water ternary emulsion with a gelled external phase | |
AU2004271753B2 (en) | Concentrated and diluted stable oil/water emulsions | |
JPH11507650A (en) | Rinse cosmetic cleansing composition | |
KR20140073902A (en) | Oil-drop type cosmetic composition | |
CN109966184A (en) | A kind of suspension oil droplet makeup remover and preparation method thereof | |
JP4637992B2 (en) | Microcapsule and manufacturing method thereof | |
JP4642950B2 (en) | Makeup removal cosmetic | |
JPS6078907A (en) | Double-layered cosmetic | |
JP4332062B2 (en) | Water-in-oil whitening cosmetic | |
CN105050665B (en) | Personal care composition comprising coated sugar | |
JP2000239139A (en) | Skin cosmetic | |
JPH08245363A (en) | Solid o/w-type emulsion cosmetic | |
JPS6112882B2 (en) | ||
JP3524445B2 (en) | Freshener composition | |
JP3555907B2 (en) | Solid oil-in-water emulsified cosmetic | |
JPH05310529A (en) | Cosmetic or ornamentation | |
JPH11222415A (en) | Double layer type hair cosmetic | |
JP2001199865A (en) | Bleaching cosmetic | |
KR100256781B1 (en) | Cosmetic softener composition containing much oil | |
KR102688155B1 (en) | Comsmetic composition comprising pearl pigment coated with silica bead and manufacturing method thereof | |
JP2732261B2 (en) | Skin composition | |
JPH0145444B2 (en) | ||
JPS61176511A (en) | Solubilized water-based clear cosmetic |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
LAPS | Cancellation because of no payment of annual fees |